Illinois consumers who bought certain generic prescription drugs from May 2009 through December 2019 may now seek compensation from settlements totaling about $96.5 million, Attorney General Kwame Raoul announced Wednesday.
The claims notice covers eligible purchases of drugs made by Glenmark, Lannett, Bausch, Apotex or Heritage. Consumers can review the drug list and submit a claim through the settlement administrator at AGGenericDrugs.com, call 866-290-0182 or email info@AGGenericDrugs.com. The announcement did not state a claim deadline, so buyers should rely on the administrator’s current instructions rather than assume a date.
The money comes from five agreements resolving allegations—not admissions or trial findings—that manufacturers participated in conspiracies to fix prices, allocate customers and suppress competition. A federal judge in Connecticut granted preliminary approval this month to a plan for distributing money to consumers, according to Raoul’s office.
How the settlements reached $96.5 million
The state’s total combines several agreements. Illinois and other attorneys general announced a $29.6 million settlement with Glenmark in July. That agreement also requires cooperation in the continuing litigation and internal compliance reforms.
In February, the coalition reached $17.85 million in settlements with Lannett and Bausch. Earlier agreements required Apotex to pay $39.1 million and Heritage to pay $10 million, according to the attorney general’s 2024 announcement. Those figures add to $96.55 million; the state rounded the current total to approximately $96.5 million.
The broader enforcement effort began with three multistate complaints filed starting in 2016. They accuse nearly 50 drugmakers of coordinating price increases and customer allocation across hundreds of generic drugs. The allegations include communications among sales and pricing executives at dinners, conferences and by phone, email and text. Cases against other defendants continue.
What Illinois buyers should check
Eligibility depends on the manufacturer, the specific medicine and when it was purchased. The covered products span tablets, capsules, creams and other forms used for conditions ranging from infections and high blood pressure to cancer and epilepsy. Buying any generic drug during the decade-long window does not automatically qualify someone.
Consumers should compare their medication history with the administrator’s list and keep pharmacy records, insurance statements or receipts that may help document a purchase. The administrator—not the attorney general’s office—will determine individual eligibility and payment amounts under the court-approved process.
The distribution plan is nationwide, so Illinois does not receive a fixed public allotment from the total fund. Individual recoveries will depend on the number of valid claims and the plan approved by the court. That distinction matters because the headline settlement figure is not the amount available only to Illinois residents, and it should not be read as a promise of any particular payment.
Raoul joined a bipartisan coalition of 47 attorneys general in urging claims. For Illinois households, the immediate consequence is practical: the litigation has moved from settlements on paper to a process that may return money to qualifying purchasers.
